Evaluation of cannabinoid type 2 receptor expression and pyridine-based radiotracers in brains from a mouse model of Alzheimer’s disease
Neuroinflammation plays an important role in the pathophysiology of Alzheimer’s disease. The cannabinoid type 2 receptor (CB2R) is an emerging target for neuroinflammation and therapeutics of Alzheimer’s disease. Here, we aim to assess the alterations in brain CB2R levels and evaluate novel CB2R ima...
Saved in:
Main Authors: | Vasil Kecheliev, Francesco Spinelli, Adrienne Herde, Achi Haider, Linjing Mu, Jan Klohs, Simon M. Ametamey, Ruiqing Ni |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnagi.2022.1018610/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cannabinoids and the endocannabinoid system in liver diseases
by: Anna Parfieniuk-Kowerda, et al.
Published: (2024-12-01) -
Expression profile of cannabinoid receptor 2 in ovine ileum during prenatal development
by: Mehmet Özbek, et al. -
Cannabinoid type-1 receptors in CaMKII neurons drive impulsivity in pathological eating behavior
by: Elena Martin-Garcia, et al.
Published: (2025-02-01) -
Cerebrospinal fluid β2-microglobulin promotes the tau pathology through microglia–astrocyte communication in Alzheimer's disease
by: Zehu Sheng, et al.
Published: (2025-01-01) -
Synthetic CB1 Cannabinoids Promote Tunneling Nanotube Communication, Cellular Migration, and Epithelial–Mesenchymal Transition in Pancreatic PANC-1 and Colorectal SW-620 Cancer Cell Lines
by: David A. Bunsick, et al.
Published: (2025-01-01)